These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 5603007

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M.
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract] [Full Text] [Related]

  • 23. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M, Szymański A, Chetkowski A, Tarocińska B.
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract] [Full Text] [Related]

  • 24. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S.
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract] [Full Text] [Related]

  • 25. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP, Agarwala MC, Singh SK.
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract] [Full Text] [Related]

  • 26. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O, Oka S, Kawamori Y, Gomi J, Sugiyama K.
    Saishin Igaku; 1970 Jul 10; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract] [Full Text] [Related]

  • 27. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK, Singh SK.
    Indian J Chest Dis; 1973 Jan 10; 15(1):16-20. PubMed ID: 4695462
    [No Abstract] [Full Text] [Related]

  • 28. [Experimental therapy with so-called "minor" tuberculostatics].
    Freerksen E.
    Wien Med Wochenschr; 1966 Oct 15; 116(42):874-7. PubMed ID: 6005730
    [No Abstract] [Full Text] [Related]

  • 29. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I.
    Scand J Respir Dis Suppl; 1970 Oct 15; 71():192-5. PubMed ID: 5271985
    [No Abstract] [Full Text] [Related]

  • 30. [Results of outpatient treatment of tuberculous patients in a rural area of the Moldavian SSR].
    Degtiarev VP.
    Probl Tuberk; 1974 Oct 15; (9):10-2. PubMed ID: 4277915
    [No Abstract] [Full Text] [Related]

  • 31. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M, Zachara A.
    Gruzlica; 1968 Oct 15; 37(1):31-8. PubMed ID: 5720035
    [No Abstract] [Full Text] [Related]

  • 32. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN, Gur'ian IE, Kochetov BI.
    Probl Tuberk; 1972 Oct 15; 50(11):21-4. PubMed ID: 4630564
    [No Abstract] [Full Text] [Related]

  • 33. [Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis].
    Naegeli HR.
    Schweiz Med Wochenschr; 1966 Apr 16; 96(15):495-500. PubMed ID: 4293638
    [No Abstract] [Full Text] [Related]

  • 34. [The treatment of urogenital tuberculosis with current drugs].
    König K, May P.
    Urologe; 1968 Apr 16; 7(1):23-9. PubMed ID: 4297580
    [No Abstract] [Full Text] [Related]

  • 35. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb 16; 43(2):91-5. PubMed ID: 5678013
    [No Abstract] [Full Text] [Related]

  • 36. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M.
    Med Clin North Am; 1967 Sep 16; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract] [Full Text] [Related]

  • 37. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS, Bialik IB.
    Probl Tuberk; 1969 Sep 16; 47(6):23-8. PubMed ID: 4311969
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H, Opl G.
    Prax Pneumol; 1968 Nov 16; 22(11):692-8. PubMed ID: 5714048
    [No Abstract] [Full Text] [Related]

  • 39. [Use of drugs of secondary group in complex therapy of children with chronic tuberculosis].
    Rushchak VA.
    Pediatr Akus Ginekol; 1971 Nov 16; 2():24-5. PubMed ID: 4254375
    [No Abstract] [Full Text] [Related]

  • 40. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F, Perusi O.
    G Ital Mal Torace; 1966 Nov 16; 20(6):365-78. PubMed ID: 5997781
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.